CClinicalTrials.gg
CompletedNCT03406013Updated Jul 29, 2020

Internet-Based Exercise and Diet Support in Prostate Cancer Survivors

An interventional study of Written Information and Prescription in Cancer Survivor and Prostate Carcinoma, sponsored by OHSU Knight Cancer Institute. Completed at 2 sites in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-07-29.

Sponsored by OHSU Knight Cancer Institute · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
206
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Study summary

This pilot clinical trial studies how well the True NTH Community of Wellness internet-based exercise and diet support works in improving diet and exercise habits in prostate cancer survivors. Internet-based exercise and diet support may help better control treatment-related side effects and symptoms, better overall quality of life, and lower risk factors associated with cancer progression.

Read the detailed description

PRIMARY OBJECTIVES:

I. To determine the feasibility and acceptability of the Community of Wellness web portal among prostate cancer survivors by conducting a randomized controlled study comparing four levels of web-based content and interaction with participants.

SECONDARY OBJECTIVES:

I. To compare efficacy of four levels of web-based content in the Community of Wellness web portal in a pilot randomized controlled trial on exercise and dietary habits, self-efficacy for behavior change, motivation for exercise, and changes in treatment-related side effects.

OUTLINE: Patients are assigned to 1 of 4 groups.

GROUP I: Patients receive "Written Information" which includes access to the TrueNTH open access portal that provides basic written information about exercise and diet.

GROUP II: Patients receive access to "Written Information + Prescription", including written information plus additional an exercise prescription and tailored diet recommendations.

GROUP III: Patients receive access to "Written Information + Prescription + Technology", including written information, exercise prescription + diet recommendation and additional technology components. Patients complete diet and exercise behavior logs and receive educational and motivational text messages about healthy diet and exercise habits.

GROUP IV: Patients receive access to "Written Information + Prescription + Technology + Coaching" and receive written information, exercise prescription + diet recommendation, technology support and a 30-minute (each) diet and exercise consultation plus the ability to receive ongoing advice from coaches via the web portal.

After completion of intervention, patients are followed up at 3 months.

02

Conditions studied

  • Cancer Survivor
  • Prostate Carcinoma

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Self-reported prostate cancer diagnosis
  • Able to read English on a computer screen
  • Able to access a computer, tablet or smartphone at home or public location
  • Access to a device capable of receiving plain text messages
  • A personal email address

Exclusion criteria

Exclusion Criteria:

  • Men who have contraindications to exercise based the American College of Sports Medicine 2016 Exercise pre-participation screening criteria and who do not receive a physician clearance to participate in the moderate intensity physical activity with one or more of the following self-reported conditions:

    • heart attack
    • heart surgery, cardiac catheterization, or coronary angioplasty
    • pacemaker/implantable cardiac defibrillator/rhythm disturbance
    • heart valve disease
    • heart failure
    • heart transplantation
    • congenital heart disease
    • diabetes
    • kidney (renal) disease
    • chest discomfort with exertion
    • unreasonable breathlessness
    • dizziness, fainting or blackouts
    • ankle swelling
    • unpleasant awareness of forceful, rapid or irregular heart rate
    • burning or cramping sensations in your lower legs when walking short distance
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
206 participants (actual)

Study arms

  • Active comparator
    Group I

    Written Information

    Behavioral: Written Information

  • Experimental
    Group II

    Written Information Prescription

    Behavioral: Written Information · Behavioral: Prescription

  • Experimental
    Group III

    Written Information Prescription Technology

    Behavioral: Written Information · Behavioral: Prescription · Behavioral: Technology

  • Experimental
    Group IV

    Written Information Prescription Technology Coaching

    Behavioral: Written Information · Behavioral: Prescription · Behavioral: Technology · Behavioral: Coaching

Interventions

  • BehavioralWritten Information

    Receive written information on diet and exercise relevant to older men with prostate cancer

  • BehavioralPrescription

    Participants receive tailored exercise prescription and tailored diet recommendations

  • BehavioralTechnology

    Participants receive motivational text messages and can electronically log and track their exercise and diet habits

  • BehavioralCoaching

    Participants receive access to an exercise and diet coach to provide advice by phone and/or email

05

What researchers measure

Primary outcomes

  1. Accrual success

    Measured as ability to recruit target sample size within one year

    Time frame: Up to 3 months

  2. Retention

    Measured as the % of men who complete post-intervention and follow-up measures out of the total # of men enrolled

    Time frame: Up to 6 months

  3. Adherence to the study

    Measured as the # of times that a man visits the portal over three months

    Time frame: Up to 3 months

Secondary outcomes

  1. Community Healthy Activities Model Program for Seniors (CHAMPS) physical activity survey

    CHAMPS estimates total weekly energy expenditure (in kilocalories per week) from low to vigorous intensity physical activities for older adults.

    Time frame: Baseline, 3 months, and 6 months

  2. Harvard T.H. Chan School of Public Health Food Frequency Questionnaire for adults from 2007

    This 132-item survey assesses dietary intake over the past month in categories from "never or less than once per month" to "6 or more times per day" and supports examining major food and nutrient categories of the U.S. diet.

    Time frame: Baseline, 3 months, and 6 months

  3. Self-Efficacy for Exercise

    A 6-item measure of Self-efficacy for Exercise will be used. Summed scores range from 6-30, and higher scores indicate higher self-efficacy.

    Time frame: Baseline, 3 months, and 6 months

  4. Physical Activity Stage Assessment

    This 5-question measure asks the person to select one description, from a choice of five, which describes his current activity behavior.

    Time frame: Baseline, 3 months, and 6 months

  5. Charlson Comorbidity Index

    The Charlson Comorbidity Index is a weighted index to predict mortality. Scores range from 0-37, with higher scores indicating more chronic medical conditions.

    Time frame: Baseline, 3 months, and 6 months

  6. Self-Efficacy for Diet

    Diet self-efficacy will be measured by having participants rate their confidence in performing each recommended task (e.g., two more servings of cooked tomatoes per week) using a Likert scale.

    Time frame: Baseline, 3 months, and 6 months

  7. Pittsburgh Sleep Quality Index

    This self-report questionnaire assesses sleep quality and disturbances over a 1-month time interval. Nineteen individual items generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The sum of scores for these seven components yields one global score.

    Time frame: Baseline, 3 months, and 6 months

  8. Memorial Anxiety Scale for Prostate Cancer (MAX-PC)

    MAX-PC is an 18 item scale to facilitate the identification and assessment of men with prostate cancer-related anxiety. This scale consists of three subscales that measure general prostate cancer anxiety, anxiety related to prostate specific antigen (PSA) levels in particular, and fear of recurrence.

    Time frame: Baseline, 3 months, and 6 months

  9. PROMIS 7-item Short Form - Fatigue

    PROMIS - Fatigue evaluates self-reported symptoms of fatigue, from mild subjective feelings of tiredness to an overwhelming sense of exhaustion over the past seven days.

    Time frame: Baseline, 3 months, and 6 months

  10. Behavioral Regulation in Exercise Questionnaire (BREQ2)

    BREQ2 measures the continuum of behavioral regulation in exercise psychology research. This questionnaire concerns the reasons why a person exercises regularly, works out, or engages in other such physical activities. It is structured so that it asks one question and provides responses that represent external regulation, introjected regulation, identified regulation, and intrinsic motivation.

    Time frame: Baseline, 3 months, and 6 months

  11. European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)

    EORTC QLQ-C30 is a 30-item questionnaire developed to assess the quality of life of cancer patients and has five functional scales (physical, role, cognitive, emotional, and social), three symptom scales (fatigue, pain, and nausea and vomiting), a global health status / QoL scale, and a number of single items assessing additional symptoms commonly reported by cancer patients (dyspnea, loss of appetite, insomnia, constipation and diarrhea) and perceived financial impact of the disease. Scores range from 0-100, with higher functional scale scores indicating a higher level of healthy functioning while a higher score for a symptom scale represents a higher level of symptomatology or problems.

    Time frame: Baseline, 3 months, and 6 months

06

Study locations

2 sites
  • UCSF Medical Center-Mount Zion
    San Francisco, California 94115, United States
  • Oregon Health & Science University
    Portland, Oregon 97239, United States
07

References and documents

Publications

  • Chan JM, Van Blarigan EL, Langlais CS, Zhao S, Ramsdill JW, Daniel K, Macaire G, Wang E, Paich K, Kessler ER, Beer TM, Lyons KS, Broering JM, Carroll PR, Kenfield SA, Winters-Stone KM. Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial. J Med Internet Res. 2020 Dec 31;22(12):e19238. doi: 10.2196/19238. PubMed 33382378 ↗
  • Winters-Stone KM, Kenfield SA, Van Blarigan EL, Moe EL, Ramsdill JW, Daniel K, Macaire G, Paich K, Kessler ER, Kucuk O, Gillespie TW, Lyons KS, Beer TM, Broering JM, Carroll PR, Chan JM. Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2018 Nov 15;7(11):e11257. doi: 10.2196/11257. PubMed 30442638 ↗
08

Registry details

Key details

Study ID
NCT03406013
Lead sponsor
OHSU Knight Cancer Institute
Collaborators
Movember Foundation
Responsible party
Kerri Winters (Principal Investigator, OHSU Knight Cancer Institute) — Principal investigator
First posted
Jan 23, 2018
Start date
Aug 1, 2017
Primary completion
Jul 31, 2019
Completion
Mar 31, 2020
Last update
Jul 29, 2020

Study contacts

Kerri Winters-Stone
principal investigator · OHSU Knight Cancer Institute

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion